Clover Leaf Capital Corp. (CLOE) Research

Clover Leaf Capital Corp. currently maintains no substantial operational activities. Its primary objective is to execute a strategic business combination, which may encompass a merger, a capital stock exchange, an asset acquisition, a stock purchase, a reorganization, or similar corporate transactions, involving one or more target entities. The firm explicitly aims to concentrate its efforts on identifying opportunities within the cannabis industry. Established in 2021, its headquarters are situated in Miami, Florida.

Market snapshot

Symbol
CLOE
Price
$12.47
Day change
0.00%
Market cap
$61.9M
P/E ratio
-68.30x
52-week range
10-14.75
Sector
Financial Services
Industry
Shell Companies

Peer companies

  • Artemis Therapeutics Inc. (ATMS)
  • Focus Impact BH3 Acquisition Co (BHAC)
  • Citizens Commerce Bancshares, Inc. (CCVS)
  • Cornerstone Community Bancorp (CRSB)
  • Iris Acquisition Corp (IRAA)
  • James Maritime Holdings, Inc. (JMTM)
  • Kingswood Acquisition Corp. (KWAC)
  • OCA Acquisition Corp. (OCAX)

Recent insider activity

  • Derechin Luis — trade (0 shares) on 2023-12-21
  • Polar Asset Management Partners Inc. — J-Other (300000 shares) on 2023-07-19
  • MacLean Felipe — C-Conversion (3457806 shares) on 2023-07-20
  • MacLean Felipe — C-Conversion (3457806 shares) on 2023-07-20
  • Atlas Merchant Capital LLC — trade (0 shares) on 2022-10-19

Open Clover Leaf Capital Corp. (CLOE) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.